2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Neil J
NJ
Stone
Jennifer G
JG
Robinson
Alice H
AH
Lichtenstein
C Noel
CN
Bairey Merz
Conrad B
CB
Blum
Robert H
RH
Eckel
Anne C
AC
Goldberg
David
D
Gordon
Daniel
D
Levy
Donald M
DM
Lloyd-Jones
Patrick
P
McBride
J Sanford
JS
Schwartz
Susan T
ST
Shero
Sidney C
SC
Smith
Karol
K
Watson
Peter W F
PW
Wilson
Karen M
KM
Eddleman
Nicole M
NM
Jarrett
Ken
K
LaBresh
Lev
L
Nevo
Janusz
J
Wnek
Jeffrey L
JL
Anderson
Jonathan L
JL
Halperin
Nancy M
NM
Albert
Biykem
B
Bozkurt
Ralph G
RG
Brindis
Lesley H
LH
Curtis
David
D
DeMets
Judith S
JS
Hochman
Richard J
RJ
Kovacs
E Magnus
EM
Ohman
Susan J
SJ
Pressler
Frank W
FW
Sellke
Win-Kuang
WK
Shen
Sidney C
SC
Smith
Gordon F
GF
Tomaselli
D000572:American Heart Association; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000517:prevention & control*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D011322:Primary Prevention; D012307:Risk Factors; D055502:Secondary Prevention; D014481:United States
D000924:Anticholesteremic Agents
AHA Scientific Statements; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention